Czarnecka-Kujawa K - Search Results

1

Isolation of tumour-reactive lymphocytes from peripheral blood via microfluidic immunomagnetic cell sorting.

Wang Z, Ahmed S, Labib M, Wang H, Wu L, Bavaghar-Zaeimi F, Shokri N, Blanco S, Karim S, Czarnecka-Kujawa K, Sargent EH, McGray AJR, de Perrot M, Kelley SO. Wang Z, et al. Among authors: czarnecka kujawa k. Nat Biomed Eng. 2023 Sep;7(9):1188-1203. doi: 10.1038/s41551-023-01023-3. Epub 2023 Apr 10. Nat Biomed Eng. 2023. PMID: 37037966

2

Efficacy and Cost of Awake Thoracoscopy and Video-Assisted Thoracoscopic Surgery in the Undiagnosed Pleural Effusion.

McDonald CM, Pierre C, de Perrot M, Darling G, Cypel M, Pierre A, Waddell T, Keshavjee S, Yasufuku K, Czarnecka-Kujawa K. McDonald CM, et al. Among authors: czarnecka kujawa k. Ann Thorac Surg. 2018 Aug;106(2):361-367. doi: 10.1016/j.athoracsur.2018.02.044. Epub 2018 Mar 22. Ann Thorac Surg. 2018. PMID: 29577922

3

Endobronchial ultrasound-guided transbronchial needle aspiration mediastinal lymph node staging in malignant pleural mesothelioma.

Czarnecka-Kujawa K, de Perrot M, Keshavjee S, Yasufuku K. Czarnecka-Kujawa K, et al. J Thorac Dis. 2019 Feb;11(2):602-612. doi: 10.21037/jtd.2019.01.01. J Thorac Dis. 2019. PMID: 30963005 Free PMC article.

4

The impact of concordance with a lung cancer diagnosis pathway guideline on treatment access in patients with stage IV lung cancer.

Pattison A, Jeagal L, Yasufuku K, Pierre A, Donahoe L, Yeung J, Darling G, Cypel M, De Perrot M, Waddell T, Keshavjee S, Czarnecka-Kujawa K. Pattison A, et al. Among authors: czarnecka kujawa k. J Thorac Dis. 2020 Aug;12(8):4327-4337. doi: 10.21037/jtd-20-157. J Thorac Dis. 2020. PMID: 32944345 Free PMC article.

5

Molecular alterations in non-small-cell lung cancer: perspective for targeted therapy and specimen management for the bronchoscopist.

Czarnecka-Kujawa K, Yasufuku K. Czarnecka-Kujawa K, et al. Respirology. 2014 Nov;19(8):1117-25. doi: 10.1111/resp.12377. Respirology. 2014. PMID: 25302756 Review.

6

A Preclinical Evaluation Comparing the Performance of a Novel 19-G Flexible Needle to a Commercially Available 22-G EBUS-TBNA Sampling Needle.

Czarnecka-Kujawa K, Tremblay A, Yasufuku K, Sczaniecka A, Parthiban S, Kunz L, Dillard D, Gonzalez X. Czarnecka-Kujawa K, et al. Respiration. 2018;95(1):55-62. doi: 10.1159/000480154. Epub 2017 Oct 12. Respiration. 2018. PMID: 29020679 Free article.

7

Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer: The ACCELERATE Nonrandomized Clinical Trial.

García-Pardo M, Czarnecka-Kujawa K, Law JH, Salvarrey AM, Fernandes R, Fan ZJ, Waddell TK, Yasufuku K, Liu G, Donahoe LL, Pierre A, Le LW, Gunasegaran T, Ghumman N, Shepherd FA, Bradbury PA, Sacher AG, Schmid S, Corke L, Feng J, Stockley T, Pal P, Rogalla P, Pipinikas C, Howarth K, Ambasager B, Mezquita L, Tsao MS, Leighl NB. García-Pardo M, et al. Among authors: czarnecka kujawa k. JAMA Netw Open. 2023 Jul 3;6(7):e2325332. doi: 10.1001/jamanetworkopen.2023.25332. JAMA Netw Open. 2023. PMID: 37490292 Free PMC article. Clinical Trial.

8

Role of EBUS-TBNA/EUS-FNA and mass spectrometry for diagnosis and typing of lymph node amyloidosis: 10-year experience in two tertiary care academic centers.

Naqvi A, Bonert M, Finley C, Czarnecka-Kujawa K, Yasufuku K, Schwock J, Kulasingam V, John R, Ko HM. Naqvi A, et al. Among authors: czarnecka kujawa k. Cancer Cytopathol. 2023 Nov;131(11):724-734. doi: 10.1002/cncy.22751. Epub 2023 Aug 28. Cancer Cytopathol. 2023. PMID: 37641237

9

PD-L1 assessment in cytology samples predicts treatment response to checkpoint inhibitors in NSCLC.

Lau SCM, Rabindranath M, Weiss J, Li JJN, Fung AS, Mullen D, Alshamlan N, Ruff HM, Tong LCB, Pal P, Cabanero MR, Hsu YR, Sacher AG, Shepherd FA, Liu G, Bradbury PA, Yasufuku K, Czarnecka-Kujawa K, Mi Ko H, Tsao MS, Leighl NB, Schwock J. Lau SCM, et al. Among authors: czarnecka kujawa k. Lung Cancer. 2022 Sep;171:42-46. doi: 10.1016/j.lungcan.2022.07.018. Epub 2022 Jul 25. Lung Cancer. 2022. PMID: 35907387 Review.

10

Implementation of PD-L1 22C3 IHC pharmDxTM in Cell Block Preparations of Lung Cancer: Concordance with Surgical Resections and Technical Validation of CytoLyt® Prefixation.

Lou SK, Ko HM, Kinoshita T, MacDonald S, Weiss J, Czarnecka-Kujawa K, Boerner SL, Yasufuku K, Tsao MS, Schwock J. Lou SK, et al. Among authors: czarnecka kujawa k. Acta Cytol. 2020;64(6):577-587. doi: 10.1159/000508628. Epub 2020 Jun 29. Acta Cytol. 2020. PMID: 32599583 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

13 results

Search Page